Zaleplon

Links shared publicly online about this topic

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia

medicalnewstoday.com — “Somnus Therapeutics, Inc., a private specialty pharmaceutical company, has completed a Phase 2 dose-ranging study of SKP-1041, a modified-release formulation of zaleplon. The study (SOM201), conduView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 2, 2011 at 12:06 pm By:

mnt_sleep MNT Sleep News Health News

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia http://mnt.to/3WGs #sleep

12 months ago...

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia

medicalnewstoday.com — “Somnus Therapeutics, Inc., a private specialty pharmaceutical company, has completed a Phase 2 dose-ranging study of SKP-1041, a modified-release formulation of zaleplon. The study (SOM201), conduView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 5:15 am By:

Sleep_Wisdom Sleep OW OW Health

Somnus Therapeutics Completes Successful Phase 2 Study Of SKP-1041 For Sleep Maintenance Insomnia: Somnus Therap... http://bit.ly/iwWaDa

12 months ago...

Ambien, Sonata, and Lunesta – The Morning After | Brain Blogger

brainblogger.com — “The latest generation of sleep hypnotics -- Ambien (zolpidem), Sonata (zaleplon), and Lunesta (zopiclone) -- have introduced new terms into the AmericanView full resource at brainblogger.com

  • View Related
  • Share

Most Recently Shared on June 11, 2011 at 4:24 pm By:

DrKNDhttp://howtoclickwithpeople.com " /> Dr. Rick Kirschner CAM, Naturopathic Doctor, and Personal Development Coach

Ambien, Sonata, and Lunesta – The Morning After http://zite.to/mPDSyj via @Ziteapp

12 months ago...

Sleeping pills linked to higher risk of cancer, death, study says - South Florida Sun-Sentinel.com

sun-sentinel.com — “A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem ( Ambien ), temazepam (Restoril), eszopiclone ( Lunesta ) and zaleplon (Sonata) are more likely to develop cancer , and far more likely to die prematurely, than those who take no sleep aids.View full resource at sun-sentinel.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 8:14 am By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Sleeping pills linked to higher risk of cancer, death, study says - Sun Sentinel http://t.co/hWPCZteP #health

2 months ago...

Sleeping pills linked to higher risk of cancer, death, study says - OrlandoSentinel.com

orlandosentinel.com — “A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem ( Ambien ), temazepam (Restoril), eszopiclone ( Lunesta ) and zaleplon (Sonata) are more likely to develop cancer , and far more likely to die prematurely, than those who take no sleep aids.View full resource at orlandosentinel.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 11:53 am By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Sleeping pills linked to higher risk of cancer, death, study says - Orlando Sentinel http://t.co/kJ2fgSvG #health

2 months ago...

Sleeping pills linked to higher risk of cancer, death, study says - latimes.com

latimes.com — “A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem ( Ambien ), temazepam (Restoril), eszopiclone ( Lunesta ) and zaleplon (Sonata) are more likely to develop cancer , and far more likely to die prematurely, than those who take no sleep aids.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on February 29, 2012 at 5:23 pm By:

docphelan Darren Phelan Doctor, Emergency Physician, and Physician

No cause and effect, but compelling findings about sleep aids. http://t.co/UPTuuFZ2

3 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390